[ad_1]
After almost a year of waiting for the good news, the people of the UK finally got it; Indirectly the world. The British government was the first country in the world to authorize the use of vaccines on a large scale in response to the Corona epidemic. In this case, the wait for the ticker from your country (Oxford) did not last long; Instead, they have decided to rely on vaccines from Pfizer of the United States and Bioentech of Germany.
Pfizer-Bioentech has worked hard to create this precedent to create vaccines in the shortest time possible. It only took them 10 months to go from theory to reality. They have not eliminated any of the steps that are generally required to complete a vaccine in 10 years. Thanks to your tireless efforts, the people of the UK will soon be able to return to normal life; The whole world in phases.
Meanwhile, President Vladimir Putin has given instructions for the Russian-invented ‘Spink-V’ vaccine to be applied to the general population starting next week. Although the vaccine has been criticized for not correctly performing all the necessary tests.
According to the UK’s drug and medical device regulator MHRA, the vaccine, called BNT 162B2, provides 95 percent protection against Cavid-19. It is safe for public use. “The Pfizer vaccine meets the minimum standards that we have for approval of the vaccine,” said Matt Hancock, the British health minister.
The minister said eight lakh doses of the vaccine will be available next week. However, doses of 50 to 60 lakh will be available this month. The minister said that health workers and people in nursing homes would have priority when it comes to getting vaccinated.
So far, the effectiveness of Pfizer-Bioentech vaccines has been tested in the bodies of 43,500 people in six countries. No risky side effects were found.
Meanwhile, the British government has ordered the purchase of 40 million Tickers from Pfizer, which will cover the needs of 20 million people in the country. However, it will take until March-April to ensure vaccination for everyone. “Hopefully we can spend next summer together,” said the minister.
Prime Minister Boris Johnson said: “With this vaccine, we will be able to return to normal life and revitalize the economy.”
However, Johnson, the government’s top medical adviser, said that even if the vaccine is administered, health rules such as social distance or wearing a mask must be followed.
According to the British government, the largest immunization program in UK history will take place in three locations: hospitals, immunization centers and temporary centers. Several conference rooms and playgrounds will be used as temporary centers.
UK researchers say the Oxford vaccine could soon be approved by the British government. That could happen in the next few months. The British government has ordered Oxford to buy 100 million rupees. The total population of the country is approximately six and a half million rupees.
This Pfizer vaccine must be stored at minus 60 degrees Celsius. A person should take two doses 21 days apart. And it will take a few weeks for the body’s immune system to develop against the coronavirus. This is a new ‘mRNA’ type vaccine. The vaccine is made up of a small fraction of the genetic code of the new coronavirus. This type of vaccine (mRNA) has previously been administered experimentally to humans. This is the first time it will be applied for treatment.
“This recognition by the British government will be a historic moment in the deal with Corona,” said Albert Borla, chief executive officer of Pfizer.
Among the few vaccines that could be approved soon is a modern vaccine, the researchers said. It is also of the “mRNA” type and is 95 percent efficient. Russia has also approved the production of a vaccine called ‘Spunik-V’. The two vaccines from China are also in the final stages of testing. However, Pfizer-Bioentech has been ahead in the ticker race so far. Many more countries are expected to easily approve the vaccine, given the UK’s recognition. Meanwhile, the European Medicines Agency has called an emergency meeting. At that meeting on December 29, they will examine whether a decision can be made to use the Pfizer-Bioentech vaccine in an emergency.
Meanwhile, according to the global statistics website WorldMeter, the number of KVID-19 patients identified in 213 countries and regions of the world stands at around 64.3 million. The death toll has exceeded 14 lakh 90 thousand. The number of recoveries is not small; More than four and a half crore. A crore 72 lakh people are under treatment. Among them, an 81 lakh crore of people (99.4 percent) have mild symptoms. The rest (0.6 percent) is in critical condition. The death rate is 3 percent higher than that of those infected. Sources: BBC, AFP.
[ad_2]
